Показано 0 из 0
Дата |
---|
16:23 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.44
|
1.48
|
1.43
|
1.40
|
1.48
|
1.44
|
|
|
16 343.35
|
21.00
|
1.39
|
1.54
|
1.43
|
1.40
|
1.455
|
1.435
|
|
|
13 004.57
|
26.00
|
1.39
|
1.54
|
1.44
|
1.41
|
1.475
|
1.475
|
|
|
4 374.09
|
14.00
|
1.38
|
1.54
|
1.455
|
1.40
|
1.49
|
1.47
|
|
|
35 321.35
|
34.00
|
1.405
|
1.46
|
1.475
|
1.445
|
1.475
|
1.46
|
|
|
2 626.16
|
3.00
|
1.405
|
1.54
|
1.485
|
1.425
|
1.485
|
1.485
|
|
|
5 174.59
|
16.00
|
1.405
|
1.54
|
1.505
|
1.425
|
1.505
|
1.505
|
|
|
5 657.44
|
14.00
|
1.405
|
1.54
|
1.495
|
1.46
|
1.52
|
1.52
|
|
|
2 162.20
|
7.00
|
1.43
|
1.54
|
1.485
|
1.45
|
1.525
|
1.525
|
|
|
5 432.99
|
9.00
|
1.43
|
1.53
|
1.54
|
1.425
|
1.54
|
1.50
|
|
|
12 892.02
|
33.00
|
Oncodesign Precision Medicine specializes in the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology. The company aims to discover new targeted therapy molecules for cancers without current solutions, including therapy-resistant and metastatic cancers.